HEADER LIGASE 15-APR-22 7ZLO TITLE CRYSTAL STRUCTURE OF SOCS2:ELONGINB:ELONGINC IN COMPLEX WITH COMPOUND TITLE 2 12 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SUPPRESSOR OF CYTOKINE SIGNALING 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SOCS-2,CYTOKINE-INDUCIBLE SH2 PROTEIN 2,CIS-2,STAT-INDUCED COMPND 5 STAT INHIBITOR 2,SSI-2; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: ELONGIN-B; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: ELOB,ELONGIN 18 KDA SUBUNIT,RNA POLYMERASE II TRANSCRIPTION COMPND 11 FACTOR SIII SUBUNIT B,SIII P18,TRANSCRIPTION ELONGATION FACTOR B COMPND 12 POLYPEPTIDE 2; COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 3; COMPND 15 MOLECULE: ELONGIN-C; COMPND 16 CHAIN: C; COMPND 17 SYNONYM: ELOC,ELONGIN 15 KDA SUBUNIT,RNA POLYMERASE II TRANSCRIPTION COMPND 18 FACTOR SIII SUBUNIT C,SIII P15,TRANSCRIPTION ELONGATION FACTOR B COMPND 19 POLYPEPTIDE 1; COMPND 20 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SOCS2, CIS2, SSI2, STATI2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: ELOB, TCEB2; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 14 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_COMMON: HUMAN; SOURCE 18 ORGANISM_TAXID: 9606; SOURCE 19 GENE: ELOC, TCEB1; SOURCE 20 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 21 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS E3 LIGASE, SUPPRESSOR OF CYTOKINE SIGNALING, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR S.RAMACHANDRAN,A.CIULLI,N.MAKUKHIN REVDAT 4 01-MAY-24 7ZLO 1 REMARK REVDAT 3 25-OCT-23 7ZLO 1 JRNL REVDAT 2 11-OCT-23 7ZLO 1 JRNL REVDAT 1 26-APR-23 7ZLO 0 JRNL AUTH S.RAMACHANDRAN,N.MAKUKHIN,K.HAUBRICH,M.NAGALA,B.FORRESTER, JRNL AUTH 2 D.M.LYNCH,R.CASEMENT,A.TESTA,E.BRUNO,R.GITTO,A.CIULLI JRNL TITL STRUCTURE-BASED DESIGN OF A PHOSPHOTYROSINE-MASKED COVALENT JRNL TITL 2 LIGAND TARGETING THE E3 LIGASE SOCS2. JRNL REF NAT COMMUN V. 14 6345 2023 JRNL REFN ESSN 2041-1723 JRNL PMID 37816714 JRNL DOI 10.1038/S41467-023-41894-3 REMARK 2 REMARK 2 RESOLUTION. 2.22 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.22 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.68 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.3 REMARK 3 NUMBER OF REFLECTIONS : 19723 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.870 REMARK 3 FREE R VALUE TEST SET COUNT : 960 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 42.6800 - 4.2400 0.99 2956 158 0.1658 0.2211 REMARK 3 2 4.2400 - 3.3700 1.00 2908 156 0.1763 0.2205 REMARK 3 3 3.3700 - 2.9400 1.00 2876 138 0.2205 0.2680 REMARK 3 4 2.9400 - 2.7000 0.98 2517 141 0.2495 0.2943 REMARK 3 5 2.6500 - 2.4800 0.97 2472 121 0.2556 0.3209 REMARK 3 6 2.4800 - 2.3400 1.00 2882 138 0.2590 0.3037 REMARK 3 7 2.3400 - 2.2200 0.74 2152 108 0.2680 0.3524 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.308 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.667 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 40.67 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.95 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2881 REMARK 3 ANGLE : 0.954 3909 REMARK 3 CHIRALITY : 0.052 448 REMARK 3 PLANARITY : 0.008 492 REMARK 3 DIHEDRAL : 7.421 397 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7ZLO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-APR-22. REMARK 100 THE DEPOSITION ID IS D_1292120917. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-MAY-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5-7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9763 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 XE 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19794 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.218 REMARK 200 RESOLUTION RANGE LOW (A) : 53.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.7 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.13800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.22 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.26 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: SBC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM TRIS-BICINE, PEG 8K(9-14%), REMARK 280 ETHYLENE GLYCOL (26-20%), VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 26.18150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4540 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17140 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -44.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA B 81 REMARK 465 PRO B 105 REMARK 465 GLN B 106 REMARK 465 ASP B 107 REMARK 465 SER B 108 REMARK 465 GLY B 109 REMARK 465 SER B 110 REMARK 465 SER B 111 REMARK 465 ALA B 112 REMARK 465 ASN B 113 REMARK 465 GLU B 114 REMARK 465 GLN B 115 REMARK 465 ALA B 116 REMARK 465 VAL B 117 REMARK 465 GLN B 118 REMARK 465 GLY C 48 REMARK 465 PRO C 49 REMARK 465 GLY C 50 REMARK 465 GLN C 51 REMARK 465 PHE C 52 REMARK 465 ALA C 53 REMARK 465 GLU C 54 REMARK 465 ASN C 55 REMARK 465 GLU C 56 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 38 CE NZ REMARK 470 LYS A 63 NZ REMARK 470 ILE A 72 CD1 REMARK 470 ASP A 101 CG OD1 OD2 REMARK 470 GLU A 141 CG CD OE1 OE2 REMARK 470 ARG A 144 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 154 CD CE NZ REMARK 470 MET B 1 CG SD CE REMARK 470 LYS B 19 CG CD CE NZ REMARK 470 GLU B 41 CG CD OE1 OE2 REMARK 470 LYS B 46 CG CD CE NZ REMARK 470 ASP B 47 CG OD1 OD2 REMARK 470 ASP B 48 CG OD1 OD2 REMARK 470 ASP B 52 CG OD1 OD2 REMARK 470 ASP B 53 CG OD1 OD2 REMARK 470 LYS B 55 NZ REMARK 470 GLN B 65 CG CD OE1 NE2 REMARK 470 ASP B 82 CG OD1 OD2 REMARK 470 ASP B 83 CG OD1 OD2 REMARK 470 GLU B 91 CG CD OE1 OE2 REMARK 470 MET C 16 CG SD CE REMARK 470 LYS C 20 NZ REMARK 470 LYS C 32 CG CD CE NZ REMARK 470 LYS C 43 CG CD CE NZ REMARK 470 LEU C 46 CG CD1 CD2 REMARK 470 SER C 47 OG REMARK 470 THR C 57 OG1 CG2 REMARK 470 GLU C 59 CG CD OE1 OE2 REMARK 470 GLU C 64 CG CD OE1 OE2 REMARK 470 LYS C 80 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 153 -74.88 -120.32 REMARK 500 HIS B 10 -108.10 49.76 REMARK 500 ASP B 47 -128.19 67.19 REMARK 500 ALA B 71 66.06 -152.04 REMARK 500 ASN C 85 -176.25 -64.73 REMARK 500 REMARK 500 REMARK: NULL DBREF 7ZLO A 32 198 UNP O14508 SOCS2_HUMAN 32 198 DBREF 7ZLO B 1 118 UNP Q15370 ELOB_HUMAN 1 118 DBREF 7ZLO C 17 112 UNP Q15369 ELOC_HUMAN 17 112 SEQADV 7ZLO SER A 30 UNP O14508 EXPRESSION TAG SEQADV 7ZLO MET A 31 UNP O14508 EXPRESSION TAG SEQADV 7ZLO MET C 16 UNP Q15369 INITIATING METHIONINE SEQRES 1 A 169 SER MET GLN ALA ALA ARG LEU ALA LYS ALA LEU ARG GLU SEQRES 2 A 169 LEU GLY GLN THR GLY TRP TYR TRP GLY SER MET THR VAL SEQRES 3 A 169 ASN GLU ALA LYS GLU LYS LEU LYS GLU ALA PRO GLU GLY SEQRES 4 A 169 THR PHE LEU ILE ARG ASP SER SER HIS SER ASP TYR LEU SEQRES 5 A 169 LEU THR ILE SER VAL LYS THR SER ALA GLY PRO THR ASN SEQRES 6 A 169 LEU ARG ILE GLU TYR GLN ASP GLY LYS PHE ARG LEU ASP SEQRES 7 A 169 SER ILE ILE CYS VAL LYS SER LYS LEU LYS GLN PHE ASP SEQRES 8 A 169 SER VAL VAL HIS LEU ILE ASP TYR TYR VAL GLN MET CYS SEQRES 9 A 169 LYS ASP LYS ARG THR GLY PRO GLU ALA PRO ARG ASN GLY SEQRES 10 A 169 THR VAL HIS LEU TYR LEU THR LYS PRO LEU TYR THR SER SEQRES 11 A 169 ALA PRO SER LEU GLN HIS LEU CYS ARG LEU THR ILE ASN SEQRES 12 A 169 LYS CYS THR GLY ALA ILE TRP GLY LEU PRO LEU PRO THR SEQRES 13 A 169 ARG LEU LYS ASP TYR LEU GLU GLU TYR LYS PHE GLN VAL SEQRES 1 B 118 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 B 118 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 B 118 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 B 118 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 B 118 ASP GLY LYS THR LEU GLY GLU CYS GLY PHE THR SER GLN SEQRES 6 B 118 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 B 118 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CYS ILE GLU SEQRES 8 B 118 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS SEQRES 9 B 118 PRO GLN ASP SER GLY SER SER ALA ASN GLU GLN ALA VAL SEQRES 10 B 118 GLN SEQRES 1 C 97 MET MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU SEQRES 2 C 97 PHE ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR SEQRES 3 C 97 ILE LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU SEQRES 4 C 97 ASN GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER SEQRES 5 C 97 HIS VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS SEQRES 6 C 97 VAL ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE SEQRES 7 C 97 PRO ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA SEQRES 8 C 97 ALA ASN PHE LEU ASP CYS HET JI0 A 201 37 HETNAM JI0 [4-[(2~{S})-3-[(3-ETHYL-4-FLUORANYL-PHENYL) HETNAM 2 JI0 METHYLAMINO]-2-[2-(4-FLUOROPHENYL)ETHANOYLAMINO]-3- HETNAM 3 JI0 OXIDANYLIDENE-PROPYL]PHENYL] DIHYDROGEN PHOSPHATE FORMUL 4 JI0 C26 H27 F2 N2 O6 P FORMUL 5 HOH *76(H2 O) HELIX 1 AA1 SER A 30 THR A 46 1 17 HELIX 2 AA2 THR A 54 LYS A 63 1 10 HELIX 3 AA3 VAL A 112 LEU A 116 5 5 HELIX 4 AA4 SER A 121 ASP A 135 1 15 HELIX 5 AA5 SER A 162 THR A 175 1 14 HELIX 6 AA6 ALA A 177 LEU A 181 5 5 HELIX 7 AA7 PRO A 184 GLU A 193 1 10 HELIX 8 AA8 THR B 23 LYS B 36 1 14 HELIX 9 AA9 PRO B 38 ASP B 40 5 3 HELIX 10 AB1 LEU B 57 GLY B 61 5 5 HELIX 11 AB2 THR B 63 ALA B 67 5 5 HELIX 12 AB3 PRO B 100 LYS B 104 5 5 HELIX 13 AB4 ARG C 33 LEU C 37 1 5 HELIX 14 AB5 SER C 39 SER C 47 1 9 HELIX 15 AB6 PRO C 66 TYR C 83 1 18 HELIX 16 AB7 ALA C 96 ASP C 111 1 16 SHEET 1 AA1 4 PHE A 70 ASP A 74 0 SHEET 2 AA1 4 LEU A 82 THR A 88 -1 O THR A 83 N ARG A 73 SHEET 3 AA1 4 GLY A 91 GLN A 100 -1 O LEU A 95 N ILE A 84 SHEET 4 AA1 4 LYS A 103 LEU A 106 -1 O ARG A 105 N GLU A 98 SHEET 1 AA2 8 GLN B 49 LEU B 50 0 SHEET 2 AA2 8 GLN B 42 LYS B 46 -1 N LYS B 46 O GLN B 49 SHEET 3 AA2 8 ALA B 73 PHE B 79 -1 O ALA B 78 N ARG B 43 SHEET 4 AA2 8 ASP B 2 ARG B 9 1 N MET B 6 O VAL B 75 SHEET 5 AA2 8 THR B 12 LYS B 19 -1 O ALA B 18 N VAL B 3 SHEET 6 AA2 8 GLU C 28 LYS C 32 1 O ILE C 30 N THR B 13 SHEET 7 AA2 8 TYR C 18 ILE C 22 -1 N LEU C 21 O PHE C 29 SHEET 8 AA2 8 GLU C 59 ASN C 61 1 O VAL C 60 N ILE C 22 CRYST1 55.926 52.363 77.583 90.00 108.29 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017881 0.000000 0.005909 0.00000 SCALE2 0.000000 0.019097 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013575 0.00000